Companies/Teladoc Health, Inc.

Company profile

Teladoc Health, Inc.

NYSE: TDOC · Healthcare · Medical - Healthcare Information Services

PublicHQ Purchase, NYCIK 0001477449Reports USD

#100 of 1,394 Healthcare companies by revenue38th-percentile growth

EA Score

69B

FH 64DQ 86GM 48SS 76

v0.1 · 65/100 weight · provisional

↑ filing timeliness, workforce scale · ↓ revenue growth (YoY), 3-yr revenue growth

Methodology →

Revenue TTM

$2.5B

Rev growth YoY (TTM)

-1.5%

Net income (FY)

-$200.3M

Employees

4,620

Market cap

$1.7B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$2.5B$2.5B2025

Net income-$200.3M-$200.3M2025

Operating income-$263.0M-$263.0M2025

Total assets$2.9B$2.9B2025

Liabilities$1.5B$1.5B2025

Equity$1.4B$1.4B2025

Revenue trend

FY2019 – FY2025 · USD

$138.0M

FY19

$553.3M

FY19

$1.1B

FY22

$2.0B

FY22

$2.4B

FY22

$2.6B

FY23

$2.6B

FY24

$2.5B

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Other100%

By geography

UNITED STATES82%

Non-US18%

The read

Teladoc Health, Inc. booked $2.5B in FY2025 revenue, contracting 1.5% year over year — slower than 62% of Healthcare companies we track, at a -7.9% net margin.

Peers · Healthcare

Trulieve Cannabis Corp.——Maravai LifeSciences Holdings, Inc.54D Innoviva, Inc.84B+Fortrea Holdings Inc.50D

Key facts

CEOCharles Divita

SectorHealthcare

IndustryMedical - Healthcare Information Services

HeadquartersPurchase, NY

ExchangeNYSE: TDOC

Employees4,620

IPO date2015-06-30

Latest filings

8-K2026-05-21 10-Q2026-04-30 8-K2026-04-29 DEF 14A2026-04-07 8-K2026-03-30 10-K2026-02-26 8-K2026-02-25 8-K2026-02-18

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.